Nature Communications (Oct 2018)

Rifamycin congeners kanglemycins are active against rifampicin-resistant bacteria via a distinct mechanism

  • James Peek,
  • Mirjana Lilic,
  • Daniel Montiel,
  • Aleksandr Milshteyn,
  • Ian Woodworth,
  • John B. Biggins,
  • Melinda A. Ternei,
  • Paula Y. Calle,
  • Michael Danziger,
  • Thulasi Warrier,
  • Kohta Saito,
  • Nathaniel Braffman,
  • Allison Fay,
  • Michael S. Glickman,
  • Seth A. Darst,
  • Elizabeth A. Campbell,
  • Sean F. Brady

DOI
https://doi.org/10.1038/s41467-018-06587-2
Journal volume & issue
Vol. 9, no. 1
pp. 1 – 15

Abstract

Read online

Resistance to rifamycin antibiotics, which target bacterial RNA polymerases, is a growing problem. Here, the authors identify gene clusters from soil metagenomes encoding production of rifamycin analogues that are active against rifampicin-resistant bacteria through a distinct mechanism.